28.10
1.48%
0.3993
Alkermes Plc 주식(ALKS)의 최신 뉴스
Pacer Advisors Inc. Sells 1,475,252 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Primecap Management Co. CA Has $92.29 Million Stock Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Are Options Traders Betting on a Big Move in Alkermes (ALKS) Stock? - Yahoo Finance
(ALKS) Trading Report - Stock Traders Daily
Alkermes (NASDAQ:ALKS) pulls back 6.0% this week, but still delivers shareholders respectable 5.8% CAGR over 5 years - Simply Wall St
Alkermes plc (NASDAQ:ALKS) Stock Position Decreased by Segall Bryant & Hamill LLC - MarketBeat
Substance Abuse Treatment Market Expected to Reach High Growth by 2031: Allergan PLC, Alkermes, Noramco. - openPR
Royce & Associates LP Grows Stock Holdings in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes plc (NASDAQ:ALKS) Shares Purchased by AMG National Trust Bank - MarketBeat
Brokerages Set Alkermes plc (NASDAQ:ALKS) PT at $35.42 - MarketBeat
Alkermes (NASDAQ:ALKS) Price Target Raised to $40.00 at Mizuho - MarketBeat
Alkermes plc (NASDAQ:ALKS) Shares Sold by Principal Financial Group Inc. - MarketBeat
Alkermes to Participate in Two Upcoming Investor Conferences - Lelezard
Alkermes (ALKS) to Present at Major Healthcare Conferences: Stifel and Jefferies London | ALKS Stock News - StockTitan
Trend Tracker for (ALKS) - Stock Traders Daily
Alkermes plc (NASDAQ:ALKS) Shares Purchased by Robeco Institutional Asset Management B.V. - MarketBeat
Van ECK Associates Corp Purchases 29,998 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Wellington Management Group LLP Adjusts Stake in Alkermes PLC - GuruFocus.com
Narcolepsy Insights from Alkermes Presented at Psych Congress and NEI Congress - Sleep Review
Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences - Chicago Star Media
Alkermes EVP Craig Hopkinson sells $309,168 in stock - Investing.com
Alkermes EVP Craig Hopkinson sells $309,168 in stock By Investing.com - Investing.com Australia
Insider Sale at Alkermes PLC: EVP R&D, Chief Medical Officer Cra - GuruFocus.com
Alkermes raised to buy by Stifel on increased confidence for ALKS2680 - MSN
Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GuruFocus.com
Vanguard Group Inc's Recent Transaction in Alkermes PLC Shares - GuruFocus.com
Alkermes (NASDAQ:ALKS) Shares Gap UpHere's What Happened - MarketBeat
Alkermes raised to buy by Stifel on increased confidence for ALKS2680 (NASDAQ:ALKS) - Seeking Alpha
Alkermes PLC (ALKS) Shares Up 5.57% on Nov 5 - GuruFocus.com
Alkermes (NASDAQ:ALKS) Upgraded to Buy at Stifel Nicolaus - MarketBeat
A Glimpse Into The Expert Outlook On Alkermes Through 9 Analysts - Benzinga
Stifel raises Alkermes target to $36, upgrades to buy By Investing.com - Investing.com Australia
Stifel raises Alkermes target to $36, upgrades to buy - Investing.com India
Alkermes plc (NASDAQ:ALKS) Holdings Decreased by DekaBank Deutsche Girozentrale - MarketBeat
(ALKS) Proactive Strategies - Stock Traders Daily
Short Interest in Alkermes plc (NASDAQ:ALKS) Drops By 7.9% - MarketBeat
Alkermes plc (NASDAQ:ALKS) Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Alkermes holds steady stock target with neutral rating amid royalty segment dip - Investing.com
Alkermes holds steady stock target with neutral rating amid royalty segment dip By Investing.com - Investing.com South Africa
Alkermes's SWOT analysis: innovative pipeline drives CNS stock's future - Investing.com
Alkermes Eyes Completion of Phase 2 Narcolepsy Studies in 2025 - Sleep Review
Goldman Sachs keeps Alkermes stock buy-rated ahead of milestone readouts, trims PT - Investing.com Canada
Piper Sandler cuts Alkermes stock target, keeps Overweight rating By Investing.com - Investing.com Australia
Leerink maintains Alkermes stock rating with $28 target amid financial projections - Investing.com Australia
Leerink maintains Alkermes stock rating with $28 target amid financial projections By Investing.com - Investing.com South Africa
Alkermes (NASDAQ:ALKS) PT Lowered to $30.00 - MarketBeat
Piper Sandler cuts Alkermes stock target, keeps Overweight rating - Investing.com
Alkermes' Q3 Earnings & Revenues Fall Shy of Estimates, Stock Down - MSN
Alkermes' Q3 Earnings & Revenues Fall Shy Of Estimates, Stock Down - Barchart
Alkermes' (ALKS) Overweight Rating Reiterated at Piper Sandler - MarketBeat
자본화:
|
볼륨(24시간):